Responses
Regular and young investigator award abstracts
Cellular therapies
141 PBMC-based cancer vaccines generated with microfluidics squeezing demonstrate synergistic and durable tumor reduction in combination with PD1 checkpoint and FAP targeted IL-2 variants
Compose a Response to This Article
Other responses
No responses have been published for this article.
